Trial Profile
A multiple dose-escalation clinical trial to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of ACC007 tablet after oral administration in HIV-infected patients in China
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Aug 2018
Price :
$35
*
At a glance
- Drugs Ainuovirine (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Jiangsu Aidea Pharmaceutical
- 30 Aug 2018 New trial record